drugset
drugset / Trial / NCT00685607

Study to Determine the Best Way to Measure How Quickly the Drug Can Give Relief From Sudden Diarrhea

NCT00685607 ↗

Phase 4 Completed 45 enrolled Johnson & Johnson Consumer and Personal Products Worldwide
RandomizedParallel-groupDouble-blindTreatment

Summary

For six hours following drug administration, subjects will rate the severity of specific symptoms. At the end of the six hour study, subjects will rate the overall effectiveness of the product.

Timeline

Start
2008-10
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Loperamide Small molecule 2 mg Oral
Subject Simethicone Other / unclassified 125 mg Oral

Indications

acute diarrhea